Clinical Trial Update: Therapeutic Effect and Safety of Combined Hydroxyurea With Recombinant Human Erythropoietin. [Phase 2, Phase 3]

View source ↗

Summary

This document provides an update on a Phase 2/3 study evaluating the combination of hydroxyurea and recombinant human erythropoietin for Thalassemia Intermedia,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thalassemia Intermedia

Drugs mentioned

• Erythropoietin (erythropoietin)
• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Ain Shams University | Conditions: Thalassemia Intermedia | Phase 2, Phase 3 | Status: UNKNOWN